{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:55:11Z","timestamp":1740164111833,"version":"3.37.3"},"reference-count":24,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08965"],"award-info":[{"award-number":["JP22K08965"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2024]]},"DOI":"10.5761\/atcs.oa.24-00034","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T22:14:47Z","timestamp":1722550487000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Additive Effects of Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker, on Cardioplegic Arrest in Rat Hearts"],"prefix":"10.5761","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-8502","authenticated-orcid":false,"given":"Masahiro","family":"Fujii","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kawase","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Bessho","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kotani Y, Tweddell J, Gruber P, et al. Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg 2013; 96: 923\u20139.","DOI":"10.1016\/j.athoracsur.2013.05.052"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fallouh HB, Kentish JC, Chambers DJ. Targeting for cardioplegia: arresting agents and their safety. Curr Opin Pharmacol 2009; 9: 220\u20136.","DOI":"10.1016\/j.coph.2008.11.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709\u201317.","DOI":"10.1056\/NEJM199909023411001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309\u201321.","DOI":"10.1056\/NEJMoa030207"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Alexandre J, Ollitrault P, Fischer MO, et al. Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial. Am Heart J 2019; 214: 88\u201396.","DOI":"10.1016\/j.ahj.2019.04.023"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rahman A, Jahan N, Rahman MT, et al. Potential impact of non-steroidal mineralocorticoid receptor antagonists in cardiovascular disease. Int J Mol Sci 2023; 24: 1922.","DOI":"10.3390\/ijms24031922"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Imamura T, Oshima A, Narang N, et al. Implication of mineralocorticoid receptor antagonist esaxerenone in patients with heart failure with preserved ejection fraction. Circ Rep 2021; 3: 660\u20135.","DOI":"10.1253\/circrep.CR-21-0115"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iwahana T, Saito Y, Okada S, et al. Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study. PLoS One 2021; 16: e0259485.","DOI":"10.1371\/journal.pone.0259485"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamashita H, Fujii M, Bessho R, et al. Effect of esaxerenone on ischaemia and reperfusion injury in rat hearts. Eur J Cardiothorac Surg 2023; 64: ezad405.","DOI":"10.1093\/ejcts\/ezad405"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Barudzic N, Turjacanin-Pantelic D, Zivkovic V, et al. The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart. Mol Cell Biochem 2013; 381: 301\u201311.","DOI":"10.1007\/s11010-013-1712-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fujii M, Ota K, Bessho R. Cardioprotective effect of hyperkalemic cardioplegia in an aquaporin 7-deficient murine heart. Gen Thorac Cardiovasc Surg 2020; 68: 578\u201384.","DOI":"10.1007\/s11748-019-01243-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chai W, Garrelds IM, Arulmani U, et al. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? Br J Pharmacol 2005; 145: 664\u201371.","DOI":"10.1038\/sj.bjp.0706220"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Chai W, Garrelds IM, de Vries R, et al. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone? Hypertension 2006; 47: 665\u201370.","DOI":"10.1161\/01.HYP.0000205831.39339.a5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rahman A, Sawano T, Sen A, et al. Cardioprotective effects of a nonsteroidal mineralocorticoid receptor blocker, esaxerenone, in Dahl salt-sensitive hypertensive rats. Int J Mol Sci 2021; 22: 2069.","DOI":"10.3390\/ijms22042069"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ennis IL, Perez NG. Cardiac Mineralocorticoid Receptor and the Na+\/H+ Exchanger: Spilling the Beans. Front Cardiovasc Med 2021; 7: 614279.","DOI":"10.3389\/fcvm.2020.614279"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ikeda U, Kanbe T, Nakayama I, et al. Aldosterone inhibits nitricoxide synthesis in rat vascular smooth muscle cells induced by interleukin-1b. Eur J Pharmacol (Mol Pharmacol Sect) 1995; 290: 69\u201373.","DOI":"10.1016\/0922-4106(95)90018-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 2000; 101: 594\u20137.","DOI":"10.1161\/01.CIR.101.6.594"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Matsumoto T, Kudo M, Taguchi K, et al. Effect of non-steroidal mineralocorticoid receptor blocker esaxerenone on vasoreactivity to an endothelial stimulator in superior mesenteric arteries of type 2 diabetic Goto-Kakizaki rat. Biol Pharm Bull 2022; 45: 1825\u201331.","DOI":"10.1248\/bpb.b22-00616"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Munkhjargal U, Fukuda D, Ganbaatar B, et al. A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction in diabetic C57BL\/6 mice. J Atheroscler Thromb 2023; 30: 326\u201334.","DOI":"10.5551\/jat.63382"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Saldanha C, Hearse DJ. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution. J Thorac Cardiovasc Surg 1994; 108: 279\u201390.","DOI":"10.1016\/S0022-5223(94)70010-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Keller MW, Geddes L, Spotnitz W, et al. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion. Effects of adenosine. Circulation 1991; 84: 2485\u201394.","DOI":"10.1161\/01.CIR.84.6.2485"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nilsson FN, Miller VM, Johnson CM, et al. Cardioplegia alters porcine coronary endothelial cell growth and responses to aggregating platelets. J Vasc Res 1993; 30: 43\u201352.","DOI":"10.1159\/000158974"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Gohra H, Fujimura Y, Hamano K, et al. Nitric oxide release from coronary vasculature before, during, and following cardioplegic arrest. World J Surg 1999; 23: 1249\u201353.","DOI":"10.1007\/s002689900657"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) M\u00e9tais C, Li J, Simons M, et al. Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression. Circulation 1999; 100(19 Suppl): II328\u201334.","DOI":"10.1161\/01.CIR.100.suppl_2.II-328"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/30\/1\/30_oa.24-00034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:26:32Z","timestamp":1722659192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/30\/1\/30_oa.24-00034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.24-00034","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"type":"print","value":"1341-1098"},{"type":"electronic","value":"2186-1005"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"oa.24-00034"}}